By Donato Paolo Mancini
Fresenius SE & Co. KGaA (FRE.XE) on Thursday backed its group guidance after first-quarter sales and operating profit edged higher.
Net income was 465 million euros ($511 million), flat in constant currencies. Operating profit edger higher to EUR1.11 billion, while sales grew 5% to EUR8.52 billion.
The company affirmed its group guidance, despite expected earnings dilution from the acquisition of NxStage.
At Fresenius Medical Care, the company's dialysis division, net profit, operating profit and sales all grew on-year.
Net profit was EUR318 million, operating profit was EUR551 million and sales gained 6% to EUR4.13 billion.
Write to Donato Paolo Mancini at firstname.lastname@example.org; @donatopmancini